Abstract:C‐peptide, a byproduct of insulin synthesis believed to be biologically inert, is emerging as a multifunctional molecule. C‐peptide serves an anti‐inflammatory and anti‐atherogenic role in type 1 diabetes mellitus (T1DM) and early T2DM. C‐peptide protects endothelial cells by activating AMP‐activated protein kinase α, thus suppressing the activity of NAD(P)H oxidase activity and reducing reactive oxygen species (ROS) generation. It also prevents apoptosis by regulating hyperglycemia‐induced p53 upregulation and mitochondrial adaptor p66shc overactivation, as well as reducing caspase‐3 activity and promoting expression of B‐cell lymphoma‐2. Additionally, C‐peptide suppresses platelet‐derived growth factor (PDGF)‐beta receptor and p44/p42 mitogen‐activated protein (MAP) kinase phosphorylation to inhibit vascular smooth muscle cells (VSMC) proliferation. It also diminishes leukocyte adhesion by virtue of its capacity to abolish nuclear factor kappa B (NF‐kB) signaling, a major pro‐inflammatory cascade. Consequently, it is envisaged that supplementation of C‐peptide in T1DM might ameliorate or even prevent end‐organ damage. In marked contrast, C‐peptide increases monocyte recruitment and migration through phosphoinositide 3‐kinase (PI‐3 kinase)‐mediated pathways, induces lipid accumulation via peroxisome proliferator‐activated receptor γ upregulation, and stimulates VSMC proliferation and CD4+ lymphocyte migration through Src‐kinase and PI‐3K dependent pathways. Thus, it promotes atherosclerosis and microvascular damage in late T2DM. Indeed, C‐peptide is now contemplated as a potential biomarker for insulin resistance in T2DM and linked to increased coronary artery disease risk. This shift in the understanding of the pathophysiology of diabetes from being a single hormone deficiency to a dual hormone disorder warrants a careful consideration of the role of C‐peptide as a unique molecule with promising diagnostic, prognostic, and therapeutic applications.

The Role Of Insulin C-Peptide In The Coevolution Analyses Of The Insulin Signaling Pathway: A Hint For Its Functions

Co-evolutionary Analysis of Insulin/insulin Like Growth Factor 1 Signal Pathway in Vertebrate Species.

Insulin and Its Single-Chain Analogue

Decoding the cryptic active conformation of a protein by synthetic photoscanning: insulin inserts a detachable arm between receptor domains

Structural Resolution Of A Tandem Hormone-Binding Element In The Insulin Receptor And Its Implications For Design Of Peptide Agonists

Enhancing the Activity of a Protein by Stereospecific Unfolding: CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINS

Binding Mode of Insulin Receptor and Agonist Peptide

Physiological effects and therapeutic potential of proinsulin C-peptide

Acidic Residues on the N-Terminus of Proinsulin C-Peptide Are Important for the Folding of Insulin Precursor

C‐peptide in diabetes: A player in a dual hormone disorder?

Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.

The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model

Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

Comparison and analysis of insulin sequences and their coded mRNA and DNA among different species

The A-chain of Insulin Contacts the Insert Domain of the Insulin Receptor

Research Progress of C-Peptide and Its Physiological Function

Proteomic analysis reveals novel molecules involved in insulin signaling pathway.

The Molecular Evolutionary Patterns of the Insulin/FOXO Signaling Pathway

The role of insulin signaling in the development of β-cell dysfunction and diabetes

Insulin structure and function.